The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 310 participants.
Also called NCT04733443
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 310 participants
- Sponsor
- Registry
-
NCT04733443
-
- Other papers using this trial's data
- Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04733443. Randomized; no masking; primary purpose treatment. Start 2020-12-17 (actual); primary completion 2023-01-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Biolimus
- Intervention (Device)
- SeQuent® Please Neo
- Lead sponsor
- JW Medical Systems Ltd
Record details
- Record id
cardio:ct-nct04733443- Content hash
ab755d39653d6620c78e77c11ae8fa278545b419952371498db3f0eb06b266e3